ro 32-0432 has been researched along with sb 415286 in 1 studies
| Studies (ro 32-0432) | Trials (ro 32-0432) | Recent Studies (post-2010) (ro 32-0432) | Studies (sb 415286) | Trials (sb 415286) | Recent Studies (post-2010) (sb 415286) |
|---|---|---|---|---|---|
| 56 | 0 | 13 | 116 | 0 | 52 |
| Protein | Taxonomy | ro 32-0432 (IC50) | sb 415286 (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | 1.3 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.9 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.9 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.9 | |
| Cyclin-A2 | Homo sapiens (human) | 0.38 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.38 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.104 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.1108 | |
| Cyclin-A1 | Homo sapiens (human) | 0.38 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.9 | |
| large T antigen | Betapolyomavirus macacae | 55.43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avnur, Z; Dunten, P; Gong, L; Heather Hogg, J; Hirschfeld, D; Peltz, G; Tan, YC | 1 |
1 other study(ies) available for ro 32-0432 and sb 415286
| Article | Year |
|---|---|
Discovery of potent and bioavailable GSK-3beta inhibitors.
Topics: Administration, Oral; Animals; Binding Sites; Crystallography, X-Ray; Disease Models, Animal; Drug Discovery; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Maleimides; Mice; Protein Kinase C; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship | 2010 |